NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
Braces Now Adds SprintRay 3D Printer for Custom Clear Aligners: FAQ

Braces Now has added the SprintRay 3D printer to its in-office technology, allowing the practice to produce custom clear aligners and Invisalign molds directly on-site rather than relying on external labs.
The integration aims to bring fabrication in-house for faster production, greater dimensional accuracy, and tighter control over fit and comfort, reducing treatment delays and improving responsiveness to mid-treatment changes.
Patients receive custom clear aligners faster, with better fit and comfort, and the practice can quickly adjust treatment plans without waiting for external lab turnaround times.
Braces Now has locations in Buford and Norcross, Georgia, and both locations now offer in-house clear aligner production using the SprintRay printer.
Yes, the printer directly supports Invisalign treatment by producing precise molds and aligner components in-office for patients at both the Buford and Norcross locations.
Patients across all age groups, including teenagers and adults, can benefit from the in-house production of custom clear aligners for orthodontic treatment.
It allows the orthodontic team to respond quickly to mid-treatment changes, produce new aligners or refinements without external lab delays, and maintain momentum in the treatment plan.
It reflects a broader trend of integrating dental 3D printing directly into point-of-care, making manufacturing steps that were once handled by large labs now accessible to private practices.
